Cybin Inc
Change company Symbol lookup
Select an option...
CYBN Cybin Inc
KEX Kirby Corp
DDOG Datadog Inc
CLX Clorox Co
ATTO Atento SA
TOWN TowneBank
CHWY Chewy Inc
O Realty Income Corp
AI Inc

Health Care : Pharmaceuticals | Small Cap Value
Based in Canada
Company profile

Cybin Inc. (Cybin) is a clinical-stage biopharmaceutical company. The Company is engaged in creating psychedelic-based therapeutics to address the unmet need for new treatment options for people who suffer from mental health conditions. Its development pipeline consists of deuterated psilocybin analog program (CYB003), deuterated dimethyltryptamine program (CYB004), phenethylamine derivatives program (CYB005), and technology programs. The Company is engaged in developing CYB003, a deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The Company's CYB005 is focused on the development of therapeutic phenethylamine derivatives for the treatment of potential neuroinflammation and other neurological conditions. Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands, and Ireland.


Last Trade
0.0039 (1.47%)
B/A Size

Market Hours

Closing Price
Day's Change
-0.004 (-1.48%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

Upcoming Events

CYBN's fiscal year ends in March
There are no upcoming events for CYBN

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
estimate range
Previous year's
February 16, 2023Q3 2022 Earnings Release-$0.044-$0.059 to -$0.03-$0.08
November 14, 2022Q2 2022 Earnings Release-$0.047-$0.064 to -$0.039-$0.088
August 8, 2022Q1 2022 Earnings Release-$0.055-$0.079 to -$0.063--
June 22, 2022Q4 2021 Earnings Release-$0.079-$0.08 to -$0.071--

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.